Causes of vh
Reading File
Searching for causes of vitreous hemorrhage.
search_medical_text
vitreous hemorrhage causes etiology
Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration
Page 12
GradeResponse
GradeResponse
Causes of Vitreous Hemorrhage (VH)
Vitreous hemorrhage occurs when blood enters the vitreous cavity. The causes are broadly categorized below:
Most Common Causes
| Cause | Key Details |
|---|---|
| Proliferative Diabetic Retinopathy (PDR) | #1 cause overall. Neovascularization on the retinal surface or disc bleeds into the vitreous. |
| Posterior Vitreous Detachment (PVD) | The vitreous pulls away from the retina, tearing a blood vessel. About 2/3 of VH cases with PVD have at least one retinal break; ~88% of breaks occur in the superior quadrants. |
| Retinal Breaks / Tears | A tear in the retina severs a retinal vessel. Often associated with PVD. Can progress to retinal detachment. |
| Retinal Vein Occlusion (BRVO/CRVO) | Venous occlusion leads to hemorrhagic infarction and neovascularization. |
| Sickle Cell Retinopathy | Peripheral neovascularization ("sea fan" pattern) prone to bleeding. |
Other Important Causes
Neovascular / Ischemic
- Retinal artery occlusion (with subsequent neovascularization)
- Ocular ischemic syndrome
- Radiation retinopathy
Traumatic
- Blunt or penetrating ocular trauma (most common cause in young patients)
- Terson syndrome: intracranial hemorrhage (e.g., subarachnoid hemorrhage) causing VH via sudden ICP rise
Retinal Detachment
- Rhegmatogenous retinal detachment with vessel rupture at the tear site
Vascular Anomalies
- Retinal macroaneurysm (especially in elderly hypertensive patients)
- Eales disease (idiopathic retinal vasculitis, young males)
- Coat's disease (telangiectatic vessels)
Neoplastic
- Choroidal melanoma or metastases breaking through the retina
- Retinoblastoma (in children)
Inflammatory / Infectious
- Proliferative vitreoretinopathy
- CMV retinitis, toxoplasmosis
Hematologic
- Anticoagulation therapy
- Thrombocytopenia, leukemia
Idiopathic
- Up to 10–17% of cases have no identifiable cause after workup
Image: Vitreous Hemorrhage on Fundus Photography
Left (A): Dense vitreous hemorrhage obscuring fundal view. Right (B): Significant clearing at 3 months in a 58-year-old diabetic male, with the optic disc and vessels now visible.
Key Points by Age Group
- Young patients: Trauma, sickle cell retinopathy, Eales disease
- Middle-aged: Diabetic retinopathy, retinal vein occlusion
- Elderly: PVD with retinal tear, macroaneurysm, AMD (wet type with subretinal neovascularization)
Source: Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration (p. 12)
Causes of VH & their management . Take reference from decision making in ophthalmology
search_medical_text
vitreous hemorrhage causes etiology decision making ophthalmology
Abusive Head Trauma in Infants and Children
Page 12
search_medical_text
vitreous hemorrhage management treatment decision making ophthalmology
Diabetic Retinopathy
Page 40
GradeResponse
GradeResponse
search_medical_text
vitreous hemorrhage diabetic retinopathy proliferative management anti-VEGF laser
search_medical_text
vitreous hemorrhage retinal tear PVD posterior vitreous detachment management observation
Causes of Vitreous Hemorrhage & Their Management
Primary reference: Decision Making in Ophthalmology; supplemented by Diabetic Retinopathy guidelines and Posterior Vitreous Detachment, Retinal Breaks & Lattice Degeneration.
Overview
Vitreous hemorrhage (VH) results from blood entering the vitreous cavity from any source: retinal vessels, neovascularization, or trauma. Management depends on the underlying etiology and whether the retina can be visualized.
1. Proliferative Diabetic Retinopathy (PDR) — Most Common Cause
Mechanism: Retinal ischemia → neovascularization → fragile new vessels rupture into vitreous.
Management
| Step | Intervention |
|---|---|
| Initial | Dilated exam + B-scan ultrasound (if fundus obscured) to rule out tractional/rhegmatogenous RD |
| Medical | Intravitreal Anti-VEGF (bevacizumab, ranibizumab, aflibercept) — first-line for persistent VH |
| Laser | Panretinal photocoagulation (PRP) — when media clears; destroys ischemic retina to regress NV |
| Surgical | Pars plana vitrectomy (PPV) — for nonclearing VH, tractional RD involving/threatening macula, combined traction-rhegmatogenous RD, dense premacular subhyaloid hemorrhage |
DRVS (Diabetic Retinopathy Vitrectomy Study): Early vitrectomy (within 1–6 months) yields better outcomes than late vitrectomy at 1 year (Diabetic Retinopathy guidelines, p. 40).
Pre-operative anti-VEGF (bevacizumab) before PPV reduces surgical duration, number of retinal breaks, intraoperative bleeding, and post-op VH (Cochrane review; Diabetic Retinopathy guidelines, p. 40).
2. Posterior Vitreous Detachment (PVD) with Retinal Break
Mechanism: Vitreous pulls away from retina → tears a bridging retinal vessel or creates a full-thickness retinal break.
- ~2/3 of VH with PVD have ≥1 retinal break
- ~88% of breaks are in superior quadrants
- 1/3 of those with breaks have multiple breaks (Posterior Vitreous Detachment, Retinal Breaks & Lattice Degeneration, p. 12)
Management
| Finding | Management |
|---|---|
| PVD + VH, no break seen | Serial observation; B-scan US to exclude break/RD; repeat exam as hemorrhage clears |
| PVD + retinal break, no RD | Laser retinopexy or cryotherapy to demarcate break |
| PVD + rhegmatogenous RD | Urgent PPV or scleral buckle ± vitrectomy |
| Nonclearing VH (>3 months) | PPV to clear vitreous and treat break |
3. Retinal Vein Occlusion (BRVO / CRVO)
Mechanism: Venous occlusion → retinal ischemia → neovascularization → VH.
Management
| Step | Intervention |
|---|---|
| Acute | Observation; intravitreal anti-VEGF or steroids for macular edema |
| Ischemic BRVO/CRVO with NV | Sector/panretinal laser photocoagulation |
| Nonclearing VH | PPV |
4. Trauma (Most Common Cause in Young Patients)
Mechanism: Direct vessel rupture from blunt or penetrating injury; associated with retinal tears, dialysis, or giant retinal tears.
Management
| Finding | Management |
|---|---|
| Blunt trauma + VH, no RD | B-scan US; observation; avoid anti-coagulants/aspirin; head elevation |
| Penetrating trauma | Urgent surgical exploration and PPV |
| Associated retinal break/RD | Prompt PPV ± scleral buckle |
5. Terson Syndrome
Mechanism: Rapid rise in intracranial pressure (e.g., subarachnoid hemorrhage) → vitreous/preretinal hemorrhage adjacent to optic nerve head (Abusive Head Trauma in Infants and Children, p. 12).
Management
- Treat underlying intracranial pathology (neurosurgical)
- Most VH resolves spontaneously over months
- PPV if VH is dense, nonclearing, or causing deprivation amblyopia (children)
6. Retinal Macroaneurysm
Mechanism: Arteriolar aneurysm ruptures → sub-/pre-retinal or vitreous hemorrhage, typically in elderly hypertensive patients.
Management
- Most resolve spontaneously; observation for 3–6 months
- Laser photocoagulation to the macroaneurysm if persistent or threatening macula
- PPV rarely needed for nonclearing VH
7. Sickle Cell Retinopathy
Mechanism: Peripheral vascular occlusion → "sea fan" neovascularization → VH.
Management
- Scatter laser (peripheral PRP) to sea fan lesions
- Anti-VEGF (adjunct)
- PPV for nonclearing VH — caution: high risk of iatrogenic breaks; avoid scleral buckle (can worsen sickling)
8. Wet AMD (Choroidal Neovascularization)
Mechanism: CNV breaks through RPE and retina → sub-/pre-retinal or vitreous hemorrhage.
Management
- Intravitreal anti-VEGF (bevacizumab, ranibizumab, aflibercept) — mainstay
- PPV for dense submacular hemorrhage with displacement techniques
9. Eales Disease
Mechanism: Idiopathic obliterative retinal vasculitis in young males → peripheral ischemia → NV → VH.
Management
- Systemic steroids (for active inflammation)
- Peripheral laser photocoagulation to ischemic retina
- PPV for nonclearing VH
General Algorithm for VH Management
Vitreous Hemorrhage
│
▼
B-scan ultrasound (if fundus not visible)
│
┌────┴────┐
RD present No RD
│ │
Urgent PPV Observation 4–6 weeks
+ treat underlying cause
│
VH clearing?
┌──────┴──────┐
Yes No (>3 months)
│ │
Treat cause PPV + treat cause
Key Surgical Indications for PPV in VH
- Nonclearing VH > 1–3 months
- Tractional or rhegmatogenous RD
- Dense premacular subhyaloid hemorrhage
- Only-seeing eye (earlier intervention)
- Young patients (earlier, to prevent amblyopia)
- Terson syndrome with amblyogenic VH
This is a shared conversation. Sign in to Orris to start your own chat.